Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer

被引：205

作者：

Horst, David ^{[1
]}

Kriegl, Lydia ^{[1
]}

Engel, Jutta ^{[2
]}

Kirchner, Thomas ^{[1
]}

Jung, Andreas ^{[1
]}

机构：

[1] Univ Munich, Inst Pathol, D-80337 Munich, Germany

[2] Univ Munich, Inst Med Informat Verarbeitung Biometrie & Epidem, D-80337 Munich, Germany

来源：

CANCER INVESTIGATION | 2009年 / 27卷 / 08期

关键词：

CD133; CD44; CD166; Expression; Colon; Colorectal; Cancer; Survival; EXPRESSION; SURVIVAL; PROGRESSION; MECHANISMS; CARCINOMA; DISEASE;

D O I：

10.1080/07357900902744502

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

CD133, CD44, and CD166 are cell surface markers that have recently been associated with colorectal cancer stem cells. As which of these markers has the greatest impact on patient prognosis is currently unknown, we compared their expression and prognostic significance in 110 colorectal adenocarcinomas. We demonstrate that expression of CD133 correlates with that of CD166, while both do not correlate with CD44. We show that CD133 is the best sole marker to predict low patient survival, while the combined analysis of all three markers may be superior in identification of low-, intermediate-, and high-risk cases of colorectal cancer.

引用

收藏

页码：844 / 850

页数：7

相关论文

共 24 条

[1]

Human colon cancer stem cells: A new paradigm in gastrointestinal oncology [J].

Boman, Bruce M. ;

Huang, Emina .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (17) :2828-2838

[2]

Opinion - Migrating cancer stem cells - an integrated concept of malignant tumour progression [J].

Brabletz, T ;

Jung, A ;

Spaderna, S ;

Hlubek, F ;

Kirchner, T .

NATURE REVIEWS CANCER, 2005, 5 (09) :744-749

[3]

Phenotypic characterization of human colorectal cancer stem cells [J].

Dalerba, Piero ;

Dylla, Scott J. ;

Park, In-Kyung ;

Liu, Rui ;

Wang, Xinhao ;

Cho, Robert W. ;

Hoey, Timothy ;

Gurney, Austin ;

Huang, Emina H. ;

Simeone, Diane M. ;

Shelton, Andrew A. ;

Parmiani, Giorgio ;

Castelli, Chiara ;

Clarke, Michael F. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (24) :10158-10163

[4]

Molecular staging for survival prediction of colorectal cancer patients [J].

Eschrich, S ;

Yang, I ;

Bloom, G ;

Kwong, KY ;

Boulware, D ;

Cantor, A ;

Coppola, D ;

Kruhoffer, M ;

Aaltonen, L ;

Orntoft, TF ;

Quackenbush, J ;

Yeatman, TJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3526-3535

[5]

Cancer metastasis:: Building a framework [J].

Gupta, Gaorav P. ;

Massague, Joan .

CELL, 2006, 127 (04) :679-695

[6]

The hallmarks of cancer [J].

Hanahan, D ;

Weinberg, RA .

CELL, 2000, 100 (01) :57-70

[7]

CD133 expression is an independent prognostic marker for low survival in colorectal cancer [J].

Horst, D. ;

Kriegl, L. ;

Engel, J. ;

Kirchner, T. ;

Jung, A. .

BRITISH JOURNAL OF CANCER, 2008, 99 (08) :1285-1289

[8]

Mechanisms of disease - Cancer stem cells [J].

Jordan, Craig T. ;

Guzman, Monica L. ;

Noble, Mark .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1253-1261

[9]

Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study [J].

Kojima, Motohiro ;

Ishii, Genichiro ;

Atsumi, Naho ;

Fujii, Satoshi ;

Saito, Norio ;

Ochiai, Atsushi .

CANCER SCIENCE, 2008, 99 (08) :1578-1583

[10]

A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression [J].

Kuhn, Sebastian ;

Koch, Moritz ;

Nuebel, Tobias ;

Ladwein, Markus ;

Antolovic, Dalibor ;

Klingbeil, Pamela ;

Hildebrand, Dagmar ;

Moldenhauer, Gerhard ;

Langbein, Lutz ;

Franke, Werner W. ;

Weitz, Juergen ;

Zoeller, Margot .

MOLECULAR CANCER RESEARCH, 2007, 5 (06) :553-567